Botanical species · safety record

Taxus wallichiana

The EFSA Compendium of Botanicals holds 3 constituent measurements for Taxus wallichiana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Taxus wallichiana Zucc.

3Constituent measurements
0Safety records
3Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Diterpenes2
  • Lignans1

Plant parts

  • Bark1
  • Leaves1
  • Roots and other underground parts1

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
DiterpenesLeavesSolvent extractionHPLC with standard detection methodsResolve DOI
DiterpenesBarkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LignansRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Chattopadhyay, SK., Kulshrestha, M., Tripathi, V., Saha, GC., Sharma, RP., Mehta, VK. Studies on the Himalayan yew Taxus wallichiana: Part VII - The taxoids and phenolic constituents of the roots of Taxus wallichiana. MEDICINAL CHEMISTRY, 1999, vol. 38, no. 6, p. 701-704.
  2. Shanker, K., Negi, A.S., Chattopadhyay, S.K., Sashidhara, K.V., Kaur, T., Gupta, M.L., Agrawal, P., Misra, A. Determination of paclitaxel, 10-DAB, and related taxoids in Himalayan yew using reverse phase HPLC. Journal of Herbs, Spices and Medicinal Plants, 2008, vol. 13, no. 4, p. 25-44. DOI
  3. Sun, Zhang-Hua., Chen, Yu., Guo, Yan-Qiong., Qiu, Jie., Zhu, Cui-Ge., Jin, Jing., Tang, Gui-Hua., Bu, Xian-Zhang., Yin, Sheng. Isolation and cytotoxicity evaluation of taxanes from the barks of Taxus wallichiana var. mairei. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, vol. 25, no. 6, p. 1240-1243. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue